Tango Therapeutics, ordinary share
TNGX, US87583X1090
CBONDSウォッチリストで投資を発見、保存、追跡
Cbondsウォッチリストを使用すれば、常に投資状況を最新の状態に保ち、意識的な意思決定が可能です!
Cbondsウォッチリストを使用すれば、常に投資状況を最新の状態に保ち、意識的な意思決定が可能です!
最も包括的なデータベースを探索
1 000 000
債券
100 000
株
175 910
ETF&投資信託
100 000
インデックス
最も効率的な方法でポートフォリオを追跡
|
Tango Therapeutics Inc (formerly BCTG Acquisition Corp) is an operator of a biotechnology company intended to develop novel drugs for the treatment of cancer. The company leverages the genetic principle of synthetic lethality to discover and
...
Tango Therapeutics Inc (formerly BCTG Acquisition Corp) is an operator of a biotechnology company intended to develop novel drugs for the treatment of cancer. The company leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer that are focused on three core areas, including counteracting tumor suppressor gene loss, reversing the ability of cancer cells to evade the immune system and identifying novel combinations, enabling patients to get therapies that are more effective than single-agent therapy.
|